Crescent is incorporated in the Cayman Islands.
Crescent’s headquarters are located at 300 5th Ave., Waltham, MA 02451.
Crescent was founded in 2024.
Crescent’s fiscal year ends on December 31.
Crescent is traded on Nasdaq Capital Market under the symbol CBIO.
Crescent’s CUSIP number is G2545C104.
Computershare
Shares of Crescent Biopharma stock can be purchased through a licensed securities broker.
PricewaterhouseCoopers LLP
Latham & Watkins LLP
Crescent’s SEC filings can be viewed here. All SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please click here to be directed to the email alerts page.
For investor inquiries, please email us at ir@crescentbiopharma.com.